Hydroxythiohomo sildenafil
CAS: 479073-82-0
Ref. 3D-FH24512
1mg | 440,00 € | ||
2mg | 626,00 € | ||
5mg | 969,00 € | ||
10mg | 1.403,00 € | ||
25mg | 2.806,00 € |
Produktinformation
- 5-[2-Ethoxy-5-[[4-(2-hydroxyethyl)-1-piperazinyl]sulfonyl]phenyl]-1,6-dihydro-1-methyl-3-propyl-7H-pyrazolo[4,3-d]pyrimidine-7-thion e4-[[3-(4,7-Dihydro-1-methyl-3-propyl-7-thioxo-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl]-1-piperazin
- 1-Piperazineethanol, 4-[[3-(4,7-dihydro-1-methyl-3-propyl-7-thioxo-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl]-
- Hydroxythiohomosildenafil
- 5-(2-ethoxy-5-(4-(2-hydroxyethyl)piperazin-1-ylsulfonyl)phenyl)-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidine-7(6H)-thione
- 7H-Pyrazolo[4,3-d]pyrimidine-7-thione, 5-[2-ethoxy-5-[[4-(2-hydroxyethyl)-1-piperazinyl]sulfonyl]phenyl]-1,6-dihydro-1-methyl-3-propyl-
- 5-[2-Ethoxy-5-[[4-(2-hydroxyethyl)-1-piperazinyl]sulfonyl]phenyl]-1,6-dihydro-1-methyl-3-propyl-7H-pyrazolo[4,3-d]pyrimidine-7-thione
Hydroxythiohomo sildenafil is a pharmaceutical drug that belongs to the class of PDE-5 inhibitors. It is a metabolite of sildenafil and has been shown to have similar effects as its parent compound, but with improved absorption. This drug inhibits the breakdown of cGMP by phosphodiesterase type 5 (PDE-5) in the corpus cavernosum, leading to an increase in penile erection. Hydroxythiohomo sildenafil has been shown to improve erectile function in people with diabetes mellitus and appears to be effective for treating erectile dysfunction. Hydroxythiohomo sildenafil is currently under development for the treatment of pulmonary arterial hypertension.
Chemische Eigenschaften
Technische Anfrage zu: 3D-FH24512 Hydroxythiohomo sildenafil
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.